143 related articles for article (PubMed ID: 35713205)
1. Myeloproliferative neoplasm with eosinophilia and PDGFR beta rearrangement in an infant.
Palla S; Boddu D; Matthew LG; Janet NB; Geevar T
Pediatr Blood Cancer; 2023 Jan; 70(1):e29856. PubMed ID: 35713205
[No Abstract] [Full Text] [Related]
2. [Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFR1].
Fan XS; Wang SA
Zhonghua Bing Li Xue Za Zhi; 2012 Nov; 41(11):779-83. PubMed ID: 23302345
[No Abstract] [Full Text] [Related]
3. Identification of a Novel CSNK2A1-PDGFRB Fusion Gene in a Patient with Myeloid Neoplasm with Eosinophilia.
Xu X; Lu Q; Wang Z; Cai P; Zeng Z; Zhang L; Wang M; Ma L; Ruan C; Chen S
Cancer Res Treat; 2021 Jul; 53(3):889-892. PubMed ID: 33421986
[TBL] [Abstract][Full Text] [Related]
4. [Myeloid neoplasms with eosinophilia and FGFRl rearrangement: a case report].
Li YY; Wang C; Zhang M; Du ZH; Hu RP; Bai J; Su KJ; Liu XL; Yang Y; Tan YH; Gao SJ; Li W
Zhonghua Xue Ye Xue Za Zhi; 2022 Jan; 43(1):80. PubMed ID: 35232001
[No Abstract] [Full Text] [Related]
5. Drug sensitivity profiling identifies potential therapies for myeloid neoplasm with eosinophilia driven by a novel G3BP1-PDGFRB fusion gene.
Wang J; Xu L; Li Y; Wang J; Shao Y; Lai W; Yong J; Zhao L; Wei X; Gao C; Liu D; Gao X; Zhang Y
Leuk Lymphoma; 2024 Apr; 65(4):521-525. PubMed ID: 38157478
[No Abstract] [Full Text] [Related]
6. Abnormal mast cells in myeloid neoplasm with eosinophilia and PDGFRB rearrangement.
Bourrienne MC; Debus J
Blood; 2019 Aug; 134(8):718. PubMed ID: 31439618
[No Abstract] [Full Text] [Related]
7. Myeloid/lymphoid neoplasm associated with eosinophilia and concurrent rearrangement of PDGFRA and FGFR1: A very rare pediatric case.
Wang B; Wang X; Lin J; Zhang Y; Gan W; Li T
Pediatr Blood Cancer; 2023 Oct; 70(10):e30507. PubMed ID: 37336772
[No Abstract] [Full Text] [Related]
8. Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta.
Apperley JF; Gardembas M; Melo JV; Russell-Jones R; Bain BJ; Baxter EJ; Chase A; Chessells JM; Colombat M; Dearden CE; Dimitrijevic S; Mahon FX; Marin D; Nikolova Z; Olavarria E; Silberman S; Schultheis B; Cross NC; Goldman JM
N Engl J Med; 2002 Aug; 347(7):481-7. PubMed ID: 12181402
[TBL] [Abstract][Full Text] [Related]
9. Next generation sequencing of myeloid neoplasms with eosinophilia harboring the FIP1L1-PDGFRA mutation.
Pardanani A; Lasho T; Barraco D; Patnaik M; Elala Y; Tefferi A
Am J Hematol; 2016 Mar; 91(3):E10-1. PubMed ID: 26663400
[No Abstract] [Full Text] [Related]
10. Myeloid neoplasms associated with eosinophilia and rearrangement of PDGFRA, PDGFRB, and FGFR1: a review.
Savage N; George TI; Gotlib J
Int J Lab Hematol; 2013 Oct; 35(5):491-500. PubMed ID: 23489324
[TBL] [Abstract][Full Text] [Related]
11. PDGFRᵝ-Rearranged Myeloid Neoplasm with Marked Eosinophilia in a 37-Year-Old Man; And a Literature Review.
Andrei M; Bandarchuk A; Abdelmalek C; Kundra A; Gotlieb V; Wang JC
Am J Case Rep; 2017 Feb; 18():173-180. PubMed ID: 28209946
[TBL] [Abstract][Full Text] [Related]
12. Novel t(5;11)(q32;q13.4) with NUMA1-PDGFRB fusion in a myeloid neoplasm with eosinophilia with response to imatinib mesylate.
Zou YS; Hoppman NL; Singh ZN; Sawhney S; Kotiah SD; Baer MR
Cancer Genet; 2017 Apr; 212-213():38-44. PubMed ID: 28449810
[TBL] [Abstract][Full Text] [Related]
13. Recurrent CEP85L-PDGFRB fusion in patient with t(5;6) and imatinib-responsive myeloproliferative neoplasm with eosinophilia.
Winkelmann N; Hidalgo-Curtis C; Waghorn K; Score J; Dickinson H; Jack A; Ali S; Cross NC
Leuk Lymphoma; 2013 Jul; 54(7):1527-31. PubMed ID: 23186533
[TBL] [Abstract][Full Text] [Related]
14. Atypical Phenotype and Treatment Response Pattern in a Patient with FIP1L1-PDGFRα Mutation.
Bikhchandani M; Johnson R; Tuan B; Tefferi A
Acta Haematol; 2018; 140(2):67-70. PubMed ID: 30184522
[TBL] [Abstract][Full Text] [Related]
15. Myeloid neoplasm with prominent eosinophilia and PDGFRA rearrangement treated with imatinib mesylate.
Rathe M; Kristensen TK; Møller MB; Carlsen NL
Pediatr Blood Cancer; 2010 Oct; 55(4):730-2. PubMed ID: 20589620
[TBL] [Abstract][Full Text] [Related]
16. A novel WNK1::PDGFRB fusion gene in myeloid neoplasm with eosinophilia: a case report.
Wang T; Cao J; Lin Q; Liu X; Wang M; Pei R; Lu Y
Ann Hematol; 2022 Oct; 101(10):2359-2361. PubMed ID: 35759027
[No Abstract] [Full Text] [Related]
17. Hematologic malignancies with PCM1-JAK2 gene fusion share characteristics with myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB, and FGFR1.
Patterer V; Schnittger S; Kern W; Haferlach T; Haferlach C
Ann Hematol; 2013 Jun; 92(6):759-69. PubMed ID: 23400675
[TBL] [Abstract][Full Text] [Related]
18. NDEL1-PDGFRB fusion gene in a myeloid malignancy with eosinophilia associated with resistance to tyrosine kinase inhibitors.
Byrgazov K; Kastner R; Gorna M; Hoermann G; Koenig M; Lucini CB; Ulreich R; Benesch M; Strenger V; Lackner H; Schwinger W; Sovinz P; Haas OA; van den Heuvel-Eibrink M; Niemeyer CM; Hantschel O; Valent P; Superti-Furga G; Urban C; Dworzak MN; Lion T
Leukemia; 2017 Jan; 31(1):237-240. PubMed ID: 27573554
[No Abstract] [Full Text] [Related]
19. Blood and Bone Marrow Evaluation for Eosinophilia.
Boyer DF
Arch Pathol Lab Med; 2016 Oct; 140(10):1060-7. PubMed ID: 27684977
[TBL] [Abstract][Full Text] [Related]
20. Screening for diverse PDGFRA or PDGFRB fusion genes is facilitated by generic quantitative reverse transcriptase polymerase chain reaction analysis.
Erben P; Gosenca D; Müller MC; Reinhard J; Score J; Del Valle F; Walz C; Mix J; Metzgeroth G; Ernst T; Haferlach C; Cross NC; Hochhaus A; Reiter A
Haematologica; 2010 May; 95(5):738-44. PubMed ID: 20107158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
